The current ALA market cap is 120.27M. The company's latest EPS is AUD -0.0110 and P/E is -11.82.
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 1.25M | 676k | 1.16M | 296k | 1.45M |
Operating Income | -8.63M | -10.61M | -4.81M | -8.43M | -10.19M |
Net Income | -7.8M | -9.94M | -5.05M | -8.62M | -10.18M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 16.25M | 6.71M | 10.69M | 9.21M | 5.47M |
Total Liabilities | 2.28M | 2.57M | 1.71M | 1.6M | 1.69M |
Total Equity | 13.98M | 4.14M | 8.98M | 7.62M | 3.78M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -2.5M | -2.88M | -3.55M | -6.27M | -6.4M |
Investing | -1.38M | -388k | -514k | -566k | 95k |
Financing | 8.1M | -64k | 9.8M | 6.19M | 5.41M |
Market Cap | 120.27M |
Price to Earnings Ratio | -11.82 |
Price to Sales Ratio | 81.25 |
Price to Cash Ratio | 23.21 |
Price to Book Ratio | 31.82 |
Dividend Yield | - |
Shares Outstanding | 925.16M |
Average Volume (1 week) | 927.97k |
Average Volume (1 Month) | 1.58M |
52 Week Change | 182.61% |
52 Week High | 0.185 |
52 Week Low | 0.043 |
Spread (Intraday) | 0.01 (7.41%) |
Company Name | Arovella Therapeutics Ltd |
Address |
level 3 melbourne, victoria 3053 |
Website | https://www.sudapharma.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.